Status:
COMPLETED
Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse
Lead Sponsor:
Palo Alto Medical Foundation
Conditions:
Toxoplasmosis, Cerebral
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To compare pyrimethamine and intravenous (IV) clindamycin vs. pyrimethamine and sulfonamides in the treatment of AIDS patients with central nervous system (CNS) Toxoplasma gondii.
Eligibility Criteria
Inclusion
- Exclusion Criteria
- Co-existing Condition:
- Patients with the following conditions are excluded:
- Opportunistic infection (Pneumocystis carinii pneumonia (PCP), cryptococcal meningitis) or other conditions (brain abscess) which would make treatment results difficult to interpret due to concurrent infection, disease, or therapy.
- Patients with other opportunistic infections or brain diseases are excluded.
- Patients with AIDS and cerebral toxoplasmosis.
Exclusion
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00002064
Last Update
June 24 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Palo Alto Med Foundation
Palo Alto, California, United States, 94301